Brent K. Harbaugh
Assistant Professor
Also affiliated: Utah State University (2001); Agricultural Research Service (1996–2000); United States Department of Agriculture (1996); Northeast Normal University (2006); Kansas State University (1973–2004); Royal Botanic Gardens, Kew (2006); Florida Gulf Coast University (1984–2007); The University of Kansas Health System (2020); University of Florida (1969–2019); Southwest Florida Research (2010); University of Kansas Medical Center (2021); Meridien Research (1983); Universitario Francisco de Asís (2008); Edward T. Schafer Agricultural Research Center (2007); Gramercy Research Group (United States) (2008–2014); Marymount University (2015); University of West Florida (2005–2010); Michigan State University (1986); Texas A&M University (1988)
Faculty Researcher
COM | Pathology Clinical
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Brent K. Harbaugh is an Assistant Professor in Clinical Pathology at the University of Arkansas for Medical Sciences. His research focuses on the molecular mechanisms and diagnostic markers associated with hematologic malignancies. He has published work investigating the prognostic significance of MYC expression in relation to p53 in acute lymphoblastic leukemia/lymphoma, and has also explored myelodysplastic syndromes. His clinical interests include differential diagnosis and the identification of rare medical presentations, as evidenced by case reports on cytomegalovirus (CMV) viremia and intestinal taeniasis. Harbaugh's scholarly contributions include 170 publications with 1,138 citations and an h-index of 16. He collaborates with researchers including Ankur Varma, Mamatha Gaddam, Daisy Alapat, and César Sánchez, all at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 16
- Publications: 170
- Citations: 1,143
Selected Publications
-
Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances (2025)
-
S2717 An Owl-Eyed Perspective: CMV Viremia as a Cause of Critical Illness, Pancreatitis, and Marrow Granulomas in an Immunocompetent Patient (2024)
Collaboration Network
Top Collaborators
- S2717 An Owl-Eyed Perspective: CMV Viremia as a Cause of Critical Illness, Pancreatitis, and Marrow Granulomas in an Immunocompetent Patient
- S2717 An Owl-Eyed Perspective: CMV Viremia as a Cause of Critical Illness, Pancreatitis, and Marrow Granulomas in an Immunocompetent Patient
- S2717 An Owl-Eyed Perspective: CMV Viremia as a Cause of Critical Illness, Pancreatitis, and Marrow Granulomas in an Immunocompetent Patient
- S2717 An Owl-Eyed Perspective: CMV Viremia as a Cause of Critical Illness, Pancreatitis, and Marrow Granulomas in an Immunocompetent Patient
- S2717 An Owl-Eyed Perspective: CMV Viremia as a Cause of Critical Illness, Pancreatitis, and Marrow Granulomas in an Immunocompetent Patient
- S2717 An Owl-Eyed Perspective: CMV Viremia as a Cause of Critical Illness, Pancreatitis, and Marrow Granulomas in an Immunocompetent Patient
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
- Unveiling Myelodysplastic Syndromes: Exploring Pathogenic Mechanisms and Therapeutic Advances
Similar Researchers
Based on overlapping research topics